BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 22664794)

  • 1. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
    Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T
    Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II induces tumor progression and fibrosis in intrahepatic cholangiocarcinoma through an interaction with hepatic stellate cells.
    Okamoto K; Tajima H; Ohta T; Nakanuma S; Hayashi H; Nakagawara H; Onishi I; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Tani T; Fujimura T; Kayahara M; Harada S; Wakayama T; Iseki S
    Int J Oncol; 2010 Nov; 37(5):1251-9. PubMed ID: 20878072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma.
    Ohira S; Sasaki M; Harada K; Sato Y; Zen Y; Isse K; Kozaka K; Ishikawa A; Oda K; Nimura Y; Nakanuma Y
    Am J Pathol; 2006 Apr; 168(4):1155-68. PubMed ID: 16565491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma.
    Okabe H; Beppu T; Hayashi H; Horino K; Masuda T; Komori H; Ishikawa S; Watanabe M; Takamori H; Iyama K; Baba H
    Ann Surg Oncol; 2009 Sep; 16(9):2555-64. PubMed ID: 19548033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma.
    Gentilini A; Rombouts K; Galastri S; Caligiuri A; Mingarelli E; Mello T; Marra F; Mantero S; Roncalli M; Invernizzi P; Pinzani M
    J Hepatol; 2012 Oct; 57(4):813-20. PubMed ID: 22727731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts.
    Okabe H; Beppu T; Ueda M; Hayashi H; Ishiko T; Masuda T; Otao R; Horlad H; Mima K; Miyake K; Iwatsuki M; Baba Y; Takamori H; Jono H; Shinriki S; Ando Y; Baba H
    Int J Cancer; 2012 Nov; 131(10):2234-41. PubMed ID: 22337081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma.
    Ohira S; Itatsu K; Sasaki M; Harada K; Sato Y; Zen Y; Ishikawa A; Oda K; Nagasaka T; Nimura Y; Nakanuma Y
    Pathol Int; 2006 Jul; 56(7):381-9. PubMed ID: 16792547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of stromal cell-derived factor-1alpha and its receptor CXCR4 expression accompanied with epithelial-mesenchymal transition in human oral squamous cell carcinoma.
    Taki M; Higashikawa K; Yoneda S; Ono S; Shigeishi H; Nagayama M; Kamata N
    Oncol Rep; 2008 Apr; 19(4):993-8. PubMed ID: 18357387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.
    Huang CY; Lee CY; Chen MY; Yang WH; Chen YH; Chang CH; Hsu HC; Fong YC; Tang CH
    J Cell Physiol; 2009 Oct; 221(1):204-12. PubMed ID: 19496172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H; Mansel RE; Jiang WG
    Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overactivation of the TGF-β pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells.
    Bertran E; Crosas-Molist E; Sancho P; Caja L; Lopez-Luque J; Navarro E; Egea G; Lastra R; Serrano T; Ramos E; Fabregat I
    Hepatology; 2013 Dec; 58(6):2032-44. PubMed ID: 23813475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation.
    Porcile C; Bajetto A; Barbieri F; Barbero S; Bonavia R; Biglieri M; Pirani P; Florio T; Schettini G
    Exp Cell Res; 2005 Aug; 308(2):241-53. PubMed ID: 15921680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of renin-angiotensin system independent angiotensin II production in progression and fibrosis of intrahepatic cholangiocarcinoma].
    Okamoto K; Tajima H; Ohta T; Nakanuma S; Hayashi H; Nakagawara H; Ohnishi I; Takamura H; Kitagawa H; Fushida S; Tani T; Fujimura T; Kayahara M
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2231-3. PubMed ID: 21224531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of epithelial-mesenchymal transition-related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinoma.
    Ryu HS; Chung JH; Lee K; Shin E; Jing J; Choe G; Kim H; Xu X; Lee HE; Kim DG; Lee H; Jang JJ
    Hum Pathol; 2012 Dec; 43(12):2360-70. PubMed ID: 23084587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal cell-derived factor-1α and macrophage migration-inhibitory factor induce metastatic behavior in CXCR4-expressing colon cancer cells.
    Shin HN; Moon HH; Ku JL
    Int J Mol Med; 2012 Dec; 30(6):1537-43. PubMed ID: 23023114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation.
    Hong F; Tuyama A; Lee TF; Loke J; Agarwal R; Cheng X; Garg A; Fiel MI; Schwartz M; Walewski J; Branch A; Schecter AD; Bansal MB
    Hepatology; 2009 Jun; 49(6):2055-67. PubMed ID: 19434726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.
    Zhao S; Wang J; Qin C
    J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal-derived factor-1alpha/CXCL12-CXCR 4 axis is involved in the dissemination of NSCLC cells into pleural space.
    Oonakahara K; Matsuyama W; Higashimoto I; Kawabata M; Arimura K; Osame M
    Am J Respir Cell Mol Biol; 2004 May; 30(5):671-7. PubMed ID: 14672915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis.
    Tang CH; Tan TW; Fu WM; Yang RS
    Carcinogenesis; 2008 Jan; 29(1):35-43. PubMed ID: 17916907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal cell-derived factor-1/CXC receptor 4 and β1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cells.
    Huang WS; Chin CC; Chen CN; Kuo YH; Chen TC; Yu HR; Tung SY; Shen CH; Hsieh YY; Guo SE; Shi CS; Liu TJ; Kuo HC
    J Cell Physiol; 2012 Mar; 227(3):1114-22. PubMed ID: 21567400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.